Monday, 5 October 2015

Tamatha sells HAIN 52.16: They are racing to develop better and safer treatment options with limited side effects.

Meanwhile, companies like Pfizer, Merck, Sanofi, Novo Nordisk, Novartis and Bristol-Myers Squibb are offering a wide range of drugs targeting diabetes, heart failure, and high cholesterol among others. The acquisition is slated to close later this year. Amgen will be acquiring privately held, Netherlands-based biotech company, Dezima, focused on developing treatments for dyslipidemia. Presently, heart failure treatment, omecamtiv mecarbil is in phase II development. CVD drugs comprises all classes of drugs used for the treatment of cardiovascular diseases such as hypertension, diabetes, high cholesterol, heart failure, acute stroke, abnormal rhythms of the heart, chest pain and other cardiac disorders.


Hilde:
Considering that the demand for fitness tracking devices is growing, the company with a long-term EPS growth rate of 23.8% is a good pick at the moment.

Shantay:
They display real-time feedback to encourage users to become more active.

Una:
It also offers compatible mobile applications by allowing users to track their information so that they could further interact with their personal data.

Jeana:
They typically include larger touchscreen displays, compatibility with phones, music and mobile applications.

Keisha:
These trackers, which are worn on the body typically as a wristband, record calories burned, number of steps taken and even sleeping patterns.

Bertha:
Ltd. among others have come up with fitness tracking devices like high-tech watches.

Marget:
Per data provided by the Organic Trade Association (OTA), the organic food industry now represents almost 5% of total food sales in the U.S.

Marin:
Companies like The Kroger Co., Campbell Soup Company, Boulder Brands, Inc. and The WhiteWave Foods among others have a strong presence in the organic and natural food business.

Babette:
In particular, the food industry has witnessed significant changes in terms of consumer preferences toward products with less artificial sweeteners, sodium and saturated fat.

Jaunita:
With the winds of change, companies too are not behind in making the most of the fitness rage.

The Hain Celestial Group (NASDAQ:HAIN)
//stockhand.net/us/?q=nasdaq%3Ahain&id=654398

No comments:

Post a Comment